Corient Private Wealth’s RXO RXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$821K Buy
29,773
+4,550
+18% +$100K ﹤0.01% 1919
2026
Q1
$369K Buy
25,223
+13,206
+110% +$194K ﹤0.01% 2209
2025
Q4
$152K Buy
+12,017
New +$177K ﹤0.01% 2474
2024
Q4
Sell
-8,456
Closed -$237K 2511
2024
Q3
$237K Buy
+8,456
New +$239K ﹤0.01% 2138
2024
Q1
Sell
-10,805
Closed -$251K 2352
2023
Q4
$251K Buy
+10,805
New +$217K ﹤0.01% 1960

Other funds holding RXO

Corient Private Wealth's RXO Position: Q2 2026 in Review

Corient Private Wealth increased its RXO (RXO) stake by 18% in Q2 2026, buying an estimated $100K and bringing the position to 29,773 shares worth $821K. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

Corient Private Wealth first reported a position in RXO in Q4 2023 and has held it in 5 quarters since. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Corient Private Wealth held 29,773 shares of RXO worth $821K as of Q2 2026.
  • Corient Private Wealth bought 4,550 RXO shares in Q2 2026, an estimated $100K.
  • RXO made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1919 holding.
  • Corient Private Wealth first reported a position in RXO in Q4 2023 and has held it in 5 quarters since.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.